Heart failure is a costly and deadly disease, affecting over 23 million patients worldwide, 5.8 million patients in America, half of which die within 5 years of diagnosis. In addition, heart failure costs the US government over 39 billion Dollars in health care costs annually. Systolic heart failure, resulting from cardiomyocyte loss, is the leading cause of heart failure. At the core of the pathophysiology of heart failure is the inabilit of the adult heart to regenerate. Instead, lost myocytes are replaced by fibrous tissue, which results in progressive remodeling, dilatation, and further contractile dysfunction. We recently discovered that the newborn mouse heart is able completely regenerate following injury, primarily through proliferation of pre-existing cardiomyocytes. Moreover, we identified Meis1 as a key regulator of mammalian cardiomyocyte proliferation post-natally. Our preliminary results using targeted Meis1 deletion in cardiomyocytes indicate that loss of Meis1 results in robust cardiomyocyte proliferation in the adult heart. Finally, we identified the cell cycle inhibitors p1 and p21 as potential targets for Meis1 in cardiomyocytes. Therefore, we hypothesize that Meis1 regulates cardiomyocyte proliferation through transcriptional activation of p16 and p21. We will utilize Meis1 loss of function and gain of function mouse models, as well as an array of in vivo and in vitro techniques to address this hypothesis. Ultimately, we hope to exploit our understanding of the role of Meis1 in cardiomyocyte proliferation to uncover new disease mechanisms and therapeutic approaches for cardiovascular diseases.

Public Health Relevance

Heart failure is a costly and deadly disease affecting over 5 million patients in America, half of which die within 5 years of diagnosis. The aim of this project is to determine how to make adult heart cells divide. This can potentially lead to a cure for heart failure by uncovering new strategies for regeneration of the adult heart.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Cardiovascular Differentiation and Development Study Section (CDD)
Program Officer
Wong, Renee P
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Sw Medical Center Dallas
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Eschenhagen, Thomas; Bolli, Roberto; Braun, Thomas et al. (2017) Cardiomyocyte Regeneration: A Consensus Statement. Circulation 136:680-686
Canseco, Diana C; Kimura, Wataru; Garg, Sonia et al. (2015) Human ventricular unloading induces cardiomyocyte proliferation. J Am Coll Cardiol 65:892-900
Xiao, Feng; Kimura, Wataru; Sadek, Hesham A (2015) A hippo ""AKT"" regulates cardiomyocyte proliferation. Circ Res 116:3-5
Sen, Shawdip; Sadek, Hesham A (2015) Neonatal heart regeneration: mounting support and need for technical standards. J Am Heart Assoc 4:e001727
Kimura, Wataru; Muralidhar, Shalini; Canseco, Diana C et al. (2014) Redox signaling in cardiac renewal. Antioxid Redox Signal 21:1660-73
Puente, Bao N; Kimura, Wataru; Muralidhar, Shalini A et al. (2014) The oxygen-rich postnatal environment induces cardiomyocyte cell-cycle arrest through DNA damage response. Cell 157:565-79
Mahmoud, Ahmed I; Porrello, Enzo R; Kimura, Wataru et al. (2014) Surgical models for cardiac regeneration in neonatal mice. Nat Protoc 9:305-11
Kocabas, Fatih; Zheng, Junke; Zhang, Chengcheng et al. (2014) Metabolic characterization of hematopoietic stem cells. Methods Mol Biol 1185:155-64
Zhang, Cheng Cheng; Sadek, Hesham A (2014) Hypoxia and metabolic properties of hematopoietic stem cells. Antioxid Redox Signal 20:1891-901
Porrello, Enzo R; Mahmoud, Ahmed I; Simpson, Emma et al. (2013) Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. Proc Natl Acad Sci U S A 110:187-92

Showing the most recent 10 out of 16 publications